FORA Capital LLC Purchases Shares of 13,620 The Clorox Company $CLX

Key Points

• FORA Capital LLC acquired 13,620 shares of The Clorox Company, valued at approximately $2,006,000, during the first quarter.
• Clorox reported $2.87 earnings per share (EPS) for the quarter, exceeding analysts' expectations, and has set a FY 2026 EPS guidance of 5.950-6.30.
• The company has increased its quarterly dividend to $1.24 per share, raising its annualized dividend yield to 4.2%.

FORA Capital LLC bought a new stake in The Clorox Company (NYSE:CLX - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 13,620 shares of the company's stock, valued at approximately $2,006,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Raymond James Financial Inc. lifted its holdings in Clorox by 15.6% in the first quarter. Raymond James Financial Inc. now owns 269,926 shares of the company's stock valued at $39,747,000 after acquiring an additional 36,352 shares during the period. OneDigital Investment Advisors LLC acquired a new stake in Clorox in the first quarter valued at $247,000. Brown Miller Wealth Management LLC acquired a new stake in Clorox in the first quarter valued at $399,000. Roman Butler Fullerton & Co. acquired a new stake in Clorox in the first quarter valued at $400,000. Finally, Wedge Capital Management L L P NC lifted its holdings in Clorox by 33.5% in the first quarter. Wedge Capital Management L L P NC now owns 28,510 shares of the company's stock valued at $4,198,000 after acquiring an additional 7,159 shares during the period. Institutional investors and hedge funds own 78.53% of the company's stock.

Analysts Set New Price Targets

CLX has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. reduced their target price on Clorox from $144.00 to $140.00 and set a "neutral" rating for the company in a report on Friday, July 25th. UBS Group dropped their price target on Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a research report on Thursday, July 17th. Citigroup restated a "neutral" rating and issued a $135.00 price target (down previously from $140.00) on shares of Clorox in a research report on Tuesday, July 15th. Barclays dropped their price target on Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a research report on Tuesday, July 15th. Finally, Wells Fargo & Company raised their price target on Clorox from $135.00 to $138.00 and gave the company an "equal weight" rating in a research report on Friday, August 1st. One equities research analyst has rated the stock with a Buy rating, eight have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the stock has an average rating of "Reduce" and an average price target of $143.36.

Clorox Price Performance

Clorox stock traded up $0.27 during midday trading on Friday, reaching $118.21. 1,815,992 shares of the company were exchanged, compared to its average volume of 1,831,786. The company has a market capitalization of $14.46 billion, a price-to-earnings ratio of 18.13, a P/E/G ratio of 0.94 and a beta of 0.49. The firm's 50-day simple moving average is $123.93 and its 200-day simple moving average is $134.27. The Clorox Company has a 1 year low of $116.53 and a 1 year high of $171.37. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. The firm had revenue of $1.99 billion during the quarter, compared to analysts' expectations of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm's quarterly revenue was up 4.5% compared to the same quarter last year. During the same quarter last year, the business posted $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Wednesday, August 13th were given a dividend of $1.24 per share. The ex-dividend date was Wednesday, August 13th. This represents a $4.96 dividend on an annualized basis and a yield of 4.2%. This is a boost from Clorox's previous quarterly dividend of $1.22. Clorox's dividend payout ratio (DPR) is 76.07%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.